Variant report
Variant | esv3356472 |
---|---|
Chromosome Location | chr9:96677831-96682029 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:96673909..96678084-chr9:96678410..96682250,3 | K562 | blood: | |
2 | chr9:96676732..96679654-chr9:96681245..96683320,2 | MCF-7 | breast: | |
3 | chr9:96676732..96679654-chr9:96681245..96683320,2 | MCF-7 | breast: | |
4 | chr9:96670566..96673928-chr9:96676412..96679551,4 | K562 | blood: | |
5 | chr9:96675737..96678225-chr9:96714280..96716510,2 | MCF-7 | breast: | |
6 | chr9:96678251..96680846-chr9:96690063..96691952,2 | MCF-7 | breast: | |
7 | chr9:96673909..96678084-chr9:96678410..96682250,3 | K562 | blood: | |
8 | chr9:96666033..96667879-chr9:96676753..96678543,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000131668 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543095424 | chr9:96677908-96677909 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs564790968 | chr9:96677987-96677988 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs543224246 | chr9:96678008-96678009 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs375606394 | chr9:96678018-96678019 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs116939604 | chr9:96678039-96678040 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs4744300 | chr9:96678078-96678079 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs559309345 | chr9:96678120-96678121 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs530406396 | chr9:96678126-96678127 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs540931724 | chr9:96678128-96678129 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs371970251 | chr9:96678160-96678161 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs570241034 | chr9:96678166-96678167 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs10992974 | chr9:96678178-96678179 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs187736338 | chr9:96678253-96678254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570831266 | chr9:96678278-96678279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192144600 | chr9:96678284-96678285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553054129 | chr9:96678311-96678312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184189441 | chr9:96678314-96678315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188595581 | chr9:96678337-96678338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554474195 | chr9:96678344-96678345 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192976278 | chr9:96678360-96678361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13292099 | chr9:96678382-96678383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543181441 | chr9:96678400-96678401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575392393 | chr9:96678408-96678409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551747894 | chr9:96678436-96678437 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534498854 | chr9:96678443-96678444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371409484 | chr9:96678498-96678499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs202153489 | chr9:96678535-96678536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200440840 | chr9:96678550-96678551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs386736397 | chr9:96678554-96678555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78835040 | chr9:96678558-96678559 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375998178 | chr9:96678559-96678560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558718607 | chr9:96678570-96678571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200404090 | chr9:96678583-96678584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536292664 | chr9:96678591-96678592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71366203 | chr9:96678594-96678595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201524205 | chr9:96678595-96678596 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541160226 | chr9:96678615-96678616 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149829263 | chr9:96678648-96678649 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529742800 | chr9:96678671-96678672 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542526093 | chr9:96678681-96678682 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563937573 | chr9:96678742-96678743 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540259176 | chr9:96678757-96678758 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530985019 | chr9:96678765-96678766 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12346731 | chr9:96678776-96678777 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs112979835 | chr9:96678788-96678789 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184652302 | chr9:96678800-96678801 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528569266 | chr9:96678827-96678828 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547121481 | chr9:96678833-96678834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10992975 | chr9:96678899-96678900 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs10992976 | chr9:96678904-96678905 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Mental retardation | 21693067 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Microcephaly | 18830227 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Breast cancer | 22522925 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:96671400-96679600 | Weak transcription | Gastric | stomach |
2 | chr9:96675200-96678400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr9:96676200-96678600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr9:96677000-96685200 | Weak transcription | Spleen | Spleen |
5 | chr9:96678400-96679000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr9:96678600-96678800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
7 | chr9:96679000-96680000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr9:96679000-96682600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr9:96679600-96680200 | Enhancers | Gastric | stomach |
10 | chr9:96679800-96680200 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
11 | chr9:96679800-96682400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr9:96680200-96687200 | Weak transcription | Gastric | stomach |
13 | chr9:96681400-96690600 | Weak transcription | Right Atrium | heart |